20 studies found for:    " April 04, 2007":" May 04, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 04, 2007":" May 04, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
2 Terminated PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
3 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
4 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin  (Leptin)
5 Active, not recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
6 Completed A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method
Condition: HIV Infections
Intervention: Device: intravaginal ring
7 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
8 Completed A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
Condition: HIV Infections
Interventions: Drug: dapivirine reservoir intravaginal ring;   Drug: dapivirine matrix intravaginal ring;   Other: placebo intravaginal ring
9 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
10 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
11 Completed
Has Results
The Treatment of Insomnia in Patients With HIV Disease
Conditions: HIV Infections;   Insomnia
Interventions: Drug: Doxepin;   Drug: Temazepam;   Drug: Placebo
12 Completed Mechanisms of Lipodystrophy in HIV-Infected Pateints
Condition: HIV Infections
Intervention: Drug: Viracept versus Sustiva with stavudine and epivir
13 Completed HIV and Cardiovascular Risk
Conditions: HIV Infections;   Cardiovascular Disease
Intervention:
14 Completed CMV Disease and IRIS in HIV-1 Infected Persons
Conditions: HIV Infections;   Cytomegalovirus
Intervention: Genetic: IE gene
15 Completed Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Behavioral: Nevirapine from twice-a-day to once-a-day
16 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
17 Completed Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week;   Drug: Ribavirin (Copegus®) 1600 mg/day;   Drug: Epoetin β (450 UI/kg/week)
18 Completed
Has Results
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Conditions: HIV Infections;   Meningitis
Intervention: Biological: Quadrivalent meningococcal conjugate vaccine
19 Completed
Has Results
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir
20 Completed 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
Condition: Sexually Transmitted Infections
Interventions: Other: 62% ethanol in emollient gel;   Drug: Placebo;   Other: 15% ethanol in emollient gel

Indicates status has not been verified in more than two years